Press Releases

 
Press Releases
  Date Title View
Sep 12, 2016
LYON, France, Sept. 12, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the signature of a contract for the installation of Ablatherm Robotic HIFU at the renowned Duke University Hospital located in Durham, North Carolina. Marc Oczachowski, EDAP TMS Chief Executive Officer, sai...
Sep 6, 2016
LYON, France, Sept. 06, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that Marc Oczachowski, Chief Executive Officer of EDAP TMS, is scheduled to present at the 18th Annual Rodman & Renshaw Global Investment Conference being held September 11-13, 2016 at the Lotte New York Palace ...
Aug 25, 2016
Total EDAP revenue up 20.4% year-over-year in the first six months of 2016Continued growth in HIFU system sales and treatment-driven revenue with strong marginsFocal One® 510k under FDA reviewSolid cash position at €21.9 million as of June 30, 2016LYON, France, Aug. 25, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global le...
Aug 22, 2016
LYON, France, Aug. 22, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the first prostate ablation treatments performed at Henry Ford Hospital in Detroit, Michigan, using the Company's FDA-cleared Ablatherm Robotic HIFU. This Ablatherm Robotic HIFU device is owned by HIFU Solut...
Aug 11, 2016
LYON, France, Aug. 11, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that it plans to release financial results for the second quarter ended June 30, 2016 on Thursday, August 25, 2016, during pre-market hours. Company management will host a conference call on Thursday, August...
Jun 16, 2016
LYON, France, June 16, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the first prostate ablation treatments performed at Radiosurgery of New York and Eastern Massachusetts Surgery Center, using the Company's FDA-cleared Ablatherm Robotic HIFU device deployed by HIFU USA Corp, a le...
Jun 14, 2016
LYON, France, June 14, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the first prostate ablation treatment performed at a site managed by Allied Urological Services ("Allied"), an affiliate of Austin, Texas based HealthTronics, Inc. in New York, NY, using the Company's FDA-cleared...
May 18, 2016
First quarter 2016 HIFU Division revenue increased 102% year-over-year37% growth in HIFU treatment driven revenues in Q1 2016 compared to Q1 2015€0.7 million operating profit, €1.4 million net income in first quarter 2016510(k) application for Focal One submitted to FDA LYON, France, May 18, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA ...
May 10, 2016
LYON, France, May 10, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today that it plans to release financial results for the first quarter ended March 31, 2016, on May 18, 2016, during pre-market hours.     Company management will host a conference call on Wednesday, May 18, 2016 at ...
May 4, 2016
Company to Participate in Two Plenary Sessions and Five Poster Sessions Ablatherm Treatments Performed During "L.A. Live" Pre-AUA Symposium at USCLYON, France, May 04, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that it will demonstrate the capabilities of the Ablatherm Robot...
1
... NextLast
= add release to Briefcase